Rapid Medical Announces FDA Clearance of DRIVEWIRE™ 35 and First Stroke Cases
First steerable 0.035-inch guidewire combines controlled tip deflection and distal support to accelerate catheter access; builds on nearly 5,000 DRIVEWIRE™ 24 cases
Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced U.S. Food and Drug Administration clearance of DRIVEWIRE™ 35, the first steerable 0.035-inch guidewire designed to help physicians reach the treatment site quickly and precisely during stroke and other intravascular procedures. The clearance was announced at the Society of NeuroInterventional Surgery’s (SNIS) 23rd Annual Meeting & Fellows Course.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721807284/en/ DRIVEWIRE™ 35 uses controlled tip deflection to shape the wire inside the vessel and add active steering to compatible catheters—helping physicians navigate complex anatomy and streamline access to the treatment site.
Jeremy Rempel, MD, of the University of Alberta Hospital in Edmonton, Canada, performed the first clinical cases worldwide, including successfully navigating catheters to treat an intracranial occlusion without crossing the clot.
